A 68-year-old client with end-stage pancreatic cancer is receiving morphine 4 mg IV every 4 hours PRN. The client rates pain at 8 of 10 and is grimacing. The last dose was 1 hour ago. Vital signs: respiratory rate 14, SpO2 95% on 2 L nasal cannula, BP 118/72. What is the most appropriate nursing action?

1 Wait until the 4-hour interval has elapsed before administering the next dose
2 Reduce the next morphine dose to 2 mg to avoid sedation
3 Notify the provider to escalate the dose or transition to a continuous infusion or PCA ✓ Correct answer
4 Substitute oral acetaminophen for the next morphine dose

Explanation

In end-of-life care, comfort is the priority and uncontrolled severe pain (8 of 10) signals that the current PRN regimen is inadequate. Vital signs are stable: respiratory rate 14, SpO2 95%, BP 118/72 — no sign of opioid toxicity. The nurse should advocate by notifying the provider to escalate the dose, change to scheduled dosing, or initiate a continuous infusion or PCA. Withholding the dose, reducing it, or substituting acetaminophen all violate end-of-life pain management standards.

In-depth explanation

Clinical Judgment End-of-life care priorities: comfort, dignity, symptom relief. Severe pain at 8 of 10 with stable vitals and 1 hour since last dose = PRN regimen failure. Nursing action: advocate for escalation. The doctrine of double effect permits adequate symptom relief even if it may shorten life when pain control is the intent. Memory Tip EOL pain: never withhold — escalate or transition to continuous infusion KR vs US WHO analgesic ladder, ANA palliative care standards, and Korean Hospice and Palliative Care Act all align: severe cancer pain demands continuous-infusion or PCA dosing rather than PRN. Korean tertiary palliative units routinely use morphine continuous infusion or fentanyl patches.

Clinical scenario

Clinical Practice Guide WHO analgesic ladder (cancer pain): - Step 1 mild: non-opioid (acetaminophen, NSAID) - Step 2 moderate: weak opioid (codeine, tramadol) +/- non-opioid - Step 3 severe: strong opioid (morphine, hydromorphone, fentanyl) +/- non-opioid +/- adjuvant For uncontrolled severe end-of-life cancer pain: - Transition from PRN to scheduled around-the-clock dosing - Add PRN breakthrough dose 10-20% of 24-hour total - Continuous IV infusion or PCA when frequent breakthroughs - Bowel regimen prophylactically (senna + docusate) Caution Respiratory depression risk increases with rapid dose escalation. Monitor RR, sedation (Pasero scale), and SpO2. Stable vitals here support escalation. The doctrine of double effect supports adequate analgesia even if life may be shortened, when comfort is the goal.

Key concepts

Doctrine of double effect — Ethical principle: an action with both an intended good effect (pain relief) and a foreseen unintended bad effect (potential respiratory depression) is permissible if the good outweighs the bad and the bad is not the intended outcome. Foundation of end-of-life pain management.
Patient-controlled analgesia (PCA) — Programmable IV pump that delivers a basal infusion plus client-activated bolus doses with a safety lockout. Common opioids: morphine, hydromorphone, fentanyl. Reduces total opioid use, improves pain scores, and increases client autonomy.
Palliative sedation — Use of sedatives (midazolam, propofol) to reduce consciousness in clients with refractory symptoms (severe pain, dyspnea, terminal agitation) when other measures fail. Last-resort intervention; requires informed consent and ethical review.

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

App Store Google Play

Read in another language: English 한국어 日本語繁體中文 Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.

성장을 멈추지 마세요

In-depth explanation

Clinical scenario

Key concepts

Master the NCLEX-RN with MyMerci